Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Cash Flow Reinvestment Rate
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow Reinvestment Rate of 1.20x as of September 2025, reinvesting CN¥41.69 Million (capex CN¥41.69 Million ) from operating cash flow of CN¥34.69 Million. Explore Tibet Cheezheng Tibetan Medicine Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Tibet Cheezheng Tibetan Medicine Co Ltd across 19 annual periods. Also explore 002287 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Tibet Cheezheng Tibetan Medicine Co Ltd. For live market cap and broader valuation context, see Tibet Cheezheng Tibetan Medicine Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥326.76 Million | CN¥729.70 Million | CN¥153.08 Million | ▼ -60.5% |
| 2024 | 1.13x | CN¥518.02 Million | CN¥456.75 Million | CN¥255.44 Million | ▲ +153.2% |
| 2023 | 0.45x | CN¥310.63 Million | CN¥693.41 Million | CN¥234.81 Million | ▼ -64.9% |
| 2022 | 1.28x | CN¥364.96 Million | CN¥285.69 Million | CN¥272.40 Million | ▼ -37.3% |
| 2021 | 2.04x | CN¥2.11 Billion | CN¥1.03 Billion | CN¥125.57 Million | ▼ -20.0% |
| 2020 | 2.55x | CN¥608.22 Million | CN¥238.65 Million | CN¥338.97 Million | ▲ +123.8% |
| 2019 | 1.14x | CN¥462.27 Million | CN¥405.95 Million | CN¥52.27 Million | ▲ +327.3% |
| 2018 | 0.27x | CN¥133.09 Million | CN¥499.40 Million | CN¥128.94 Million | ▼ -78.7% |
| 2017 | 1.25x | CN¥287.13 Million | CN¥229.83 Million | CN¥66.13 Million | ▲ +72.9% |
| 2016 | 0.72x | CN¥281.15 Million | CN¥389.20 Million | CN¥179.87 Million | ▼ -6.1% |
| 2015 | 0.77x | CN¥198.24 Million | CN¥257.81 Million | CN¥64.90 Million | ▲ +193.5% |
| 2014 | 0.26x | CN¥81.48 Million | CN¥310.95 Million | CN¥81.48 Million | ▼ -30.1% |
| 2013 | 0.37x | CN¥74.38 Million | CN¥198.48 Million | CN¥74.38 Million | ▲ +3.1% |
| 2012 | 0.36x | CN¥61.65 Million | CN¥169.67 Million | CN¥61.65 Million | ▼ -38.6% |
| 2010 | 0.59x | CN¥57.32 Million | CN¥96.91 Million | CN¥57.32 Million | ▲ +531.7% |
| 2009 | 0.09x | CN¥16.44 Million | CN¥175.58 Million | CN¥16.44 Million | ▼ -74.1% |
| 2008 | 0.36x | CN¥23.79 Million | CN¥65.93 Million | CN¥23.79 Million | ▲ +8.2% |
| 2007 | 0.33x | CN¥30.49 Million | CN¥91.43 Million | CN¥30.49 Million | ▼ -7.7% |
| 2006 | 0.36x | CN¥13.91 Million | CN¥38.50 Million | CN¥13.91 Million | — |